Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.23
-0.4200-0.96%
Post-market: 43.22-0.0120-0.03%18:49 EDT
Volume:17.94M
Turnover:775.90M
Market Cap:62.65B
PE:17.52
High:43.96
Open:43.51
Low:42.95
Close:43.65
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.03
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.51
PE(LYR):22.28

Loading ...

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
2 hours ago

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
2 hours ago

Press Release: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Dow Jones
·
2 hours ago

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
6 hours ago

US FDA - Classifies Imager Ii Angiographic Catheter Recall as Class I Due to Injury Risk

THOMSON REUTERS
·
Sep 26

US FDA - Boston Scientific Reports Two Serious Injuries, no Deaths from Imager Ii Catheter Defect

THOMSON REUTERS
·
Sep 26

Boston Scientific Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

US Companies Face Rise in Cyber Attacks

Reuters
·
Sep 23

Boston Scientific MedSurg, Asia Pacific Chief Arthur Butcher to Retire Jan. 1, 2027

Reuters
·
Sep 23

Movement Alert|Boston Scientific Rises 3.02% in Regular Trading, New Product Approval in China and Maintained Analyst Optimism Boost Sentiment

Market Focus
·
Sep 23

Option traders moderately bearish in Boston Scientific with shares down 0.38%

TIPRANKS
·
Sep 22

Boston Scientific Price Target Cut to $65.00/Share from $85.00 by Oppenheimer

Dow Jones
·
Sep 21

Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating

MT Newswires Live
·
Sep 21

Boston Scientific Corp. : Oppenheimer Cuts Target Price to $65 from $85

THOMSON REUTERS
·
Sep 21

Boston Scientific Shares Fall After Citigroup Downgrade

MT Newswires Live
·
Sep 18

Boston Scientific Price Target Cut to $50.00/Share from $57.00 by Citigroup

Dow Jones
·
Sep 17

U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical

Reuters
·
Sep 17

Citi Downgrades Boston Scientific, Citing Uncertain Road Ahead

Reuters
·
Sep 17

Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57

MT Newswires Live
·
Sep 17

Boston Scientific Corp : Citigroup Cuts to Neutral from Buy; Cuts Target Price to $50 from $57

THOMSON REUTERS
·
Sep 17